Abstract: We analyzed the earnings revisions of HSI component stocks for April 2026, estimating the index's 2026E EPS at HK$2,221 as of end-April, up 0.58% from HK$2,208 in March. The HSI rose 4.8% over the month (24,788 to 25,978), with 40 stocks seeing upward EPS revisions versus 29 downward, and individual stock EPS revisions contributing HK$13.4 in aggregate to the index EPS change. The largest positive contributors to index EPS were CNOOC (HK$+4.6), CCB (HK$+2.9), and HSBC (HK$+2.3), while ALIBABA (HK$-2.0) and MEITUAN (HK$-1.3) were the top detractors. At the stock level, MEITUAN posted the largest EPS upgrade (+1,487% MoM on a low base), followed by LI AUTO (+7.80%) and CNOOC (+4.96%), while BYD Electronic (-8.25%), SANDS CHINA (-3.40%), and ALIBABA (-2.99%) recorded the steepest cuts.
MEITUAN, Alibaba Health, HSBC, ALIBABA, HANSOH PHARMACEUTICAL, CCB
A monthly review of consensus earnings revisions for HSI constituents. Each issue estimates how the index's forward EPS changed over the month, and tabulates the stocks with the largest impact on index EPS alongside their EPS and revenue revisions. All issues of Index Earnings Revision Monthly →
Interested in the full report? Get in touch with our team.